Gilead Sciences Inc (NASDAQ: GILD) has reported earnings for its third fiscal quarter (ending September 30) of $1.00 versus $1.75 for the same period a year ago — a decline of -43%. For the latest four quarters through September 30, E.P.S. were $0.11 versus $4.70 for the same period a year ago — a decline of -98%.
Recent Price Action
Gilead Sciences Inc (NASDAQ: GILD) stock closed at $91.69 on 11/6/24 after an increase of 1.6%. Moreover, this advance was accompanied by above average trading volume at 138% of normal. The stock has risen 4.1% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, GILD is expected to continue to be a major Value Builder.
Gilead Sciences has a current Value Trend Rating of C (Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing contradictory signals. Gilead Sciences has a slightly negative Appreciation Score of 31 but a good Power Rating of 75, and the Neutral Value Trend Rating results.
Rating Review
In light of this new information and positive market action we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment